We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Study Questions Broad Fasting Requirements Before Routine Blood Tests

By LabMedica International staff writers
Posted on 08 Oct 2026

Routine blood testing is central to diagnosis, monitoring, and disease risk assessment. More...

Many patients are still asked to fast for 8–12 hours before phlebotomy, even though the requirement was originally intended mainly for glucose and lipid testing. Fasting can delay same-day testing and concentrate early-morning demand in hospitals and laboratories. 

Researchers from South Korea evaluated whether broad fasting requirements are necessary before routine blood testing. The proposed approach would replace a one-size-fits-all fasting rule with test-specific requirements. The analysis focused on whether results differed when patients fasted for less than 8 hours, 8–12 hours, or more than 12 hours.

The study was designed as a large-scale retrospective analysis of real-world hospital data. Researchers screened nearly 10 million routine test results collected from 670 hospitals in South Korea. The final analysis included routine blood work from 101,148 adults, with fasting duration based on time since the last meal as documented by the phlebotomist.

Statistical models were used to compare average test results across the three fasting-duration groups. To reduce the possibility that differences reflected underlying patient health, the researchers also compared the same individuals across separate visits with different fasting durations. The findings showed that blood counts, kidney function markers, electrolytes, and most liver enzymes produced similar results regardless of fasting duration.

Across 121 routine laboratory tests, only a small number showed clinically meaningful fasting-related differences. In paired within-person comparisons, 10 tests exceeded clinical error thresholds. When fasting was under 8 hours, blood glucose was 10.8% higher, triglycerides were 20.1% higher, and lipase was 36.4% higher, while glucose decreased by about 4.3 mg/dL for each additional hour of fasting.

Fasting for 8–12 hours versus more than 12 hours produced no clinically meaningful difference for any test result. The findings were published in JAMA Internal Medicine on September 28, 2026. The researchers stated that further research in more diverse populations is needed before clinical standards can be redefined.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Drug Testing Assays
Atellica DT 250 Analyzer
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Acute lymphoblastic leukemia in children and young people requires careful relapse risk assessment as treatment expands beyond standard chemotherapy. (Image Credit: Shutterstock)

New Risk-Stratification Tool Predicts Relapse After Blinatumomab in Childhood ALL

Acute lymphoblastic leukemia in children and young people requires careful assessment of relapse risk, particularly as treatment approaches move beyond standard chemotherapy. Traditional relapse predictors... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Decentralized Laboratory Network Improves Detection of Viral Hemorrhagic Fevers in Guinea

Viral hemorrhagic fevers remain a major diagnostic challenge in West Africa because their early symptoms can resemble those of other febrile illnesses. The 2014–2016 Ebola epidemic underscored the need... Read more

Pathology

view channel
Image: The automated IHC assay helps identify mesothelioma and distinguish it from other malignancies, including NSCLC. (Image Credit: Shutterstock)

Roche Launches Automated Test to Support Mesothelioma Differential Diagnosis

Mesothelioma is a rare, deadly cancer that forms in the tissue lining many internal organs. Most patients are diagnosed late, with median overall survival reported at 12 to 18 months. Differential diagnosis... Read more

Technology

view channel
Image: Diatech Pharmacogenetics launches Labcycler, a compact PCR thermal cycler. (Photo courtesy of Diatech Pharmacogenetics)

Compact PCR Thermal Cycler Launches for Routine Molecular Laboratory Workflows

Molecular laboratories rely on nucleic acid analysis to detect molecular information accurately and reproducibly across a wide range of applications. Supporting these routine workflows, a newly launched... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.